Sex hormones, heart problems and diabetes in women

Some cancer treatments lower the amount of sex hormones in the body. The main female sex hormones are oestrogen and progesterone. 

Low levels of these hormones may increase your risk of heart problems and diabetes.

Hormone therapy and the risk of heart problems

Evidence shows that before the natural menopause Open a glossary item, oestrogen can offer some protection against heart disease.

Both menopause and treatment with hormone therapy lower the levels of hormones in the body. This can increase the risk of heart problems. 

There is some evidence to suggest that aromatase inhibitors may increase the risk of heart problems. Aromatase inhibitors are a type of hormone therapy used to treat breast cancer.

The aromatase inhibitors that may increase heart problems include:

  • anastrozole (Arimidex)

  • letrozole (Femara)

Anastrozole and letrozole increase the amount of cholesterol in the blood. This side effect is especially important for people who already have heart problems.

Research also shows that tamoxifen may protect against heart problems. Tamoxifen is another type of hormone therapy used to treat breast cancer. It works by blocking the effect of oestrogen on cancer cells

Hormone therapy and the risk of diabetes 

Diabetes is a condition that causes blood sugar levels to become too high.

Insulin is a hormone that controls the level of sugar (glucose) in your blood. There is evidence that hormone therapy can increase blood sugar levels. It can make your body resistant to insulin, which keeps your blood sugar high. Insulin is important in helping glucose to be absorbed by the cells in your body.

If you already have diabetes, it may get worse if you have hormone therapy treatments. You may need to test your blood sugar level more often. You may also need to review your diabetic treatment with your doctor.

Your healthcare team will let you know more about the risk of diabetes. 

Balancing the benefits of treatments against side effects

All treatments have side effects. Doctors balance the risk of side effects against the benefits of treating the cancer.

Tamoxifen can very occasionally cause serious side effects. This includes blood clots and womb cancer. Aromatase inhibitors cause a number of side effects, including bone weakening (osteoporosis).

Starting on one type of hormone therapy and then switching to another might reduce the side effects of both. Researchers are looking at how best to use hormone treatments.

It is important to remember that these hormone treatments reduce the risk of cancer:

  • coming back
  • spreading to other parts of the body

These risks are greater than the risk of heart problems and diabetes for most people.

Talk to your healthcare team if you already have heart problems or have a high cholesterol level and are worried. 

Tips to help lower your risk of heart disease and diabetes

There are things you can do to help lower the risk of heart disease and diabetes:

  • maintain a healthy weight
  • eat a healthy well balanced diet
  • be physically active and exercise regularly

Maintaining a healthy weight

There are many benefits to maintaining a healthy weight and having a balanced diet.

Be physically active and exercise regularly 

Research has shown that exercise is safe and helpful for many people with cancer.

Talk to your GP or specialist nurse before starting any physical activity if you aren’t normally very active. They can help you work out what is best for you.

  • Aromatase Inhibitors and Risk of Metabolic and Cardiovascular Adverse Effects in Breast Cancer Patients—A Systematic Review and Meta-Analysis 
    K Boszkiewicz and others 
    Journal of Clinical Medicine, 2022. Volume 11, Issue 11, Page: 3133

  • The effect of tamoxifen on the lipid profile in women: A systematic review and meta-analysis of randomized controlled trials

    S Abdulrahman Alomar and others

    Experimental Gerontology, 2022. Volume 159, Page: 111680

  • Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis

    N Jordt and others

    Breast Cancer Research and Treatment, 2023. Volume 202, Issue 1, Pages: 11 to 22

  • Managing the side effects of tamoxifen and aromatase inhibitors

    S Conzen and others

    UpToDate website

    Accessed June 2025

  • Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors 
    A Matthews and others
    BMJ Journals, Heart, 2021. Volume 107, Issue 16, Pages 1327 to 1335

  • The information on this page is based on literature searches and specialist checking. We used many references and there are too many to list here. If you need additional references for this information please contact patientinformation@cancer.org.uk with details of the particular risk or cause you are interested in.

Last reviewed: 
12 Jun 2025
Next review due: 
12 Jun 2028

Related links